Avient Corporation
NYSE:AVNTChemicals - Specialty
+$0.04 today
- Market cap
- $4.07B
- Beta
- 1.30
- P/E (TTM)
- 21.4
- EPS (TTM)
- $1.72
- Dividend yield
- 2.97%
Volume 0.55M
Average 0.74M
AVNT EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Avient CorporationNYSE: AVNT
EBITDA · Q3 FY2026 · quarter ended Sep 2026
EBITDA grows, but more slowly than its trailing trend
Q3 FY2026 EBITDA of $128.4M rose 4.4% year over year, behind the +19.1% change in trailing-twelve-month EBITDA. Sequentially, it fell 19.9% from the prior quarter. Over 3 fiscal years it compounded at +16.5% a year.
Context
- EBITDA amounted to 16.8% of revenue in FY2025, up 1.1 pp from a year earlier.
- EBITDA increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 5 analysts of $625.72M (+14.0%) for the fiscal year ending Dec 2026, a step up from the +7.6% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $128.4M-19.9% QoQ
- Last fiscal yearDec 2025
- $548.7M+7.6% YoY
- LTMSep 2026
- $506.9M+19.1% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +4.4% | +0.2% | -4.2 pp |
| 1 year | +7.6% | +14.0% | +6.5 pp |
| 3-year CAGR | +16.5% | +7.3% | -9.2 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 548.7M USD
- Year-over-year change
- +7.6%
- 4-year CAGR
- +6.6%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 548.7M | +7.6% |
| FY2024 | 2024-12-31 | 510.1M | +30.3% |
| FY2023 | 2023-12-31 | 391.4M | +12.9% |
| FY2022 | 2022-12-31 | 346.7M | -18.3% |
| FY2021 | 2021-12-31 | 424.6M | — |
EBITDA vs competitors
How AVNT compares with its peers on the latest reported figures
- AVNT's LTM Sep 2026 EBITDA of $506.9M is the 5th highest of the 11 companies compared; the peer median is $340.76M.
- Its year-over-year change of +19.1% is the 3rd highest of 11, against a peer median of +7.1%.
- EBITDA amounts to 14.8% of revenue for AVNT, versus a peer median of 18.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $1.02B | +423.0% | +1.5% | 33.9% | |
| LTM Jun 2026 | $1.01B | +3.8% | -7.1% | 23.6% | |
| LTM Jun 2026 | $690M | -14.9% | +13.9% | 19.0% | |
| LTM Aug 2026 | $540.79M | +11.0% | +2.4% | 15.2% | |
| LTM Sep 2026 | $506.9M | +19.1% | +16.5% | 14.8% | |
| LTM Jun 2026 | $380M | +176.5% | — | 20.6% | |
| LTM Jun 2026 | $301.51M | +13.9% | +2.5% | 17.7% | |
| LTM Sep 2026 | $183.41M | +8.8% | +15.0% | 16.1% | |
| LTM Aug 2026 | $119.43M | +5.4% | +6.5% | 17.4% | |
| LTM Jun 2026 | $74.6M | -89.6% | -36.4% | 1.1% | |
| LTM Jun 2026 | -$300.15M | -303.2% | — | 39.6% | |
| Peer median (excluding AVNT) | $340.76M | +7.1% | +2.5% | 18.3% | |
Competitors are the stored peer set for AVNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 3.32B | 3.4B | 3.14B | 3.24B | 3.26B |
| Cost of Revenue | 2.37B | 2.51B | 2.24B | 2.18B | 2.2B |
| Gross Profit | 943.8M | 882.7M | 902.7M | 1.06B | 1.06B |
| Gross Margin | 28.5% | 26.0% | 28.7% | 32.6% | 32.5% |
| Research & Development | 0 | 84.9M | 90.3M | 98.7M | 0 |
| Selling, General & Admin | 664.1M | 639.4M | 590.9M | 727.4M | 695.4M |
| Operating Expenses | 664.1M | 639.4M | 681.2M | 727.4M | 854.7M |
| Depreciation & Amortization | 145.9M | 163.1M | 188.8M | 179.7M | 185.9M |
| EBITDA | 424.6M | 346.7M | 391.4M | 510.1M | 548.7M |
| EBITDA Margin | 12.8% | 10.2% | 12.5% | 15.7% | 16.8% |
| Operating Income | 279.7M | 243.3M | 221.5M | 329.3M | 203.5M |
| Operating Margin | 8.4% | 7.2% | 7.0% | 10.2% | 6.2% |
| Interest Income | 17.5M | 34M | 0 | 0 | 0 |
| Interest Expense | 105.1M | 182.3M | 115.3M | 105.6M | 98.6M |
| Other Income / Expenses | (76.2M) | (179.5M) | (134.2M) | (104.5M) | (91.8M) |
| Income Before Tax | 203.5M | 63.8M | 87.3M | 224.8M | 111.7M |
| Pre-Tax Margin | 6.1% | 1.9% | 2.8% | 6.9% | 3.4% |
| Income Tax Expense | 51.9M | (19.3M) | 11M | 54.1M | 28.1M |
| Net Income | 230.8M | 153M | 75.7M | 169.5M | 81.9M |
| Net Margin | 7.0% | 4.5% | 2.4% | 5.2% | 2.5% |
| EPS (Basic) | 2.53 | 7.71 | 0.83 | 1.86 | 0.90 |
| EPS (Diluted) | 2.51 | 1.66 | 0.82 | 1.84 | 0.89 |
| Weighted Avg Shares | 91.4M | 91.2M | 91.1M | 91.3M | 91.5M |
| Weighted Avg Shares (Diluted) | 92.1M | 92.2M | 91.8M | 92M | 91.8M |
Avient Corporation
NYSE:AVNT
Intrinsic Alpha fair value
Locked
Current Price
$44.34
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.